Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-15-001483

Chief Financial Officer sold 317,272 shares at an average $0.91 ($289,136)

  • Chief Financial Officer acquired 317,272 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Jeong Tae Heum · Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2015-01-08 Exercise or conversion : show line 1 in the form +78,782 $0.80 $63,026 583,782 D
2015-01-08 Sale : show line 2 in the form −78,782 $0.90 $70,935 505,000 D
2015-01-09 Exercise or conversion : show line 3 in the form +188,690 $0.80 $150,952 693,690 D
2015-01-09 Sale : show line 4 in the form −188,690 $0.92 $172,708 505,000 D
2015-01-12 Exercise or conversion : show line 5 in the form +49,800 $0.80 $39,840 554,800 D
2015-01-12 Sale : show line 6 in the form −49,800 $0.91 $45,492 505,000 D
Open-market sales · 317,272 sh · avg $0.91 · $289,136

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-01-08 Exercise or conversion : show line 7 in the form Stock Option (right to purchase) −78,782 $0.80 2015-01-20 78,782 421,218 D
2015-01-09 Exercise or conversion : show line 8 in the form Stock Option (right to purchase) −188,690 $0.80 2015-01-20 188,690 232,528 D
2015-01-12 Exercise or conversion : show line 9 in the form Stock Option (right to purchase) −49,800 $0.80 2015-01-20 49,800 182,728 D
Loading xslF345X03/doc1.xml…